Showing results (131-140 of 182) with videos related to
Sort By:
Pageof 19
BMC Nephrology|November 25, 2011
Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal functionKisara Onda, Isao Ohsawa, Hiroyuki Ohi, et al.Nephrology (Carlton, Vic.)|June 11, 2004
A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urineAtsushi Kurusu, Toshiyuki Yamada, Kenji Yamaji, et al.Case Reports in Nephrology and Urology|December 1, 2012
Thyroid storm masked by hemodialysis and glucocorticoid therapy in a patient with rheumatoid arthritisYohei Sasaki, Yoshio Shimizu, Junichiro Nakata, et al.Journal of Clinical Laboratory Analysis|August 19, 2014
Impact of Body Mass Index on Progression of IgA Nephropathy Among Japanese PatientsMamiko Shimamoto, Isao Ohsawa, Hiyori Suzuki, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2004
Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta miceQiuling Fan, Jie Liao, Michimasa Kobayashi, et al.Scientific Reports|December 19, 2018
Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular diseaseKeiko Takahashi, Seiji Ueda, Takashi Kobayashi, et al.Metabolism: Clinical and Experimental|May 12, 2009
Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J miceShinji Hagiwara, Tomohito Gohda, Mitsuo Tanimoto, et al.BMC Nephrology|June 15, 2014
Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathyKenji Satake, Yoshio Shimizu, Yohei Sasaki, et al.Journal of Clinical Laboratory Analysis|March 25, 2010
Metabolic impact on serum levels of complement component 3 in Japanese patientsIsao Ohsawa, Hiroyuki Inoshita, Masaya Ishii, et al.Metabolism: Clinical and Experimental|December 5, 2006
Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stressMinfang Zhang, Shinji Hagiwara, Masukazu Matsumoto, et al.Pageof 19